Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-07-05 Zausner Meryl Director Grant or award +31,746 $3.15 $100K 31,746
2022-06-22 Zausner Meryl Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-22 Zausner Meryl Director Grant or award · Stock Option (right to buy) +35,000 35,000
2021-06-16 Zausner Meryl Director Grant or award · Stock Option (right to buy) +23,000 23,000
2020-06-18 Zausner Meryl Director Grant or award · Stock Option (right to buy) +30,000 30,000

Page 1 of 1 · 5 trades